IBM’s Volatile June Sets Up a Pivotal Earnings Moment as AI and Quantum Bets Converge

A curious duality defines IBM today. The same stock that suffered a sharp June sell-off — triggered by a rival’s cautious forecast and amplified by its own sobering research — has since clawed back nearly 7% in a single week, hovering around €247.40. That remains roughly 15% below the year’s high, a gap that underscores just how split investor sentiment has become. On one side lies a mature software-and-services business that generates reliable cash; on the other, an audacious bet on quantum computing and an evolving AI portfolio that promises future growth but brings heightened uncertainty.

The June rout was less about IBM’s own fundamentals and more about industry jitters. Mid-month, Accenture slashed its 2026 revenue outlook, reviving fears that generative AI tools could cannibalise traditional IT services. IBM was caught in the downdraft. To make matters worse, the company published a study showing that 91% of executives do not fully grasp their own AI dependencies. For the market, that read as a warning that large-scale AI projects remain at risk of delay. Yet no formal earnings warning came from IBM itself. The pullback looked like a classic sentiment-driven correction after the stock had become overbought following a rally to its record peak.

Now the focus shifts squarely to July 22, when IBM reports second-quarter results after the US market close. Analysts expect earnings per share of $2.96 on revenue of roughly $17.8 billion. The real spotlight, however, falls on the company’s AI order backlog — last pegged at over $12.5 billion. Investors want to see that these commitments are flowing into the income statement. Within the software unit, management has guided for annual growth above 10%. A print that holds that level would confirm the AI engine is running; any slip into single digits could validate June’s anxiety.

Should investors sell immediately? Or is it worth buying IBM?

Two recent developments reinforce the bull case. During Wimbledon 2026, IBM rolled out a revamped digital experience powered by its watsonx platform. Fans receive hyper-personalised match analysis, real-time win probability updates, and a chatbot that serves up relevant video clips instantly. Behind the scenes, a tool called IBM Bob migrated the tournament’s entire digital archive — 15,000 articles and videos — in just 47 minutes, a task that used to take specialists months. The Wimbledon stage puts AI directly in front of millions, offering a powerful proof-of-concept.

Separately, in April, IBM secured FedRAMP authorisation for 11 AI solutions, making them available on Amazon’s government cloud. That quadrupled the company’s certified AI offering for US federal agencies in a single year. The next strategic milestone is the highest security clearance for classified government data, which management expects by late 2026 or early 2027. Achieving that would unlock sensitive intelligence and military applications, deepening IBM’s moat in public-sector tech.

Quantum computing provides the longer arc. IBM is pouring more than $10 billion into the field over the next five years, targeting the first fault-tolerant quantum computer by 2029. The company already has over 90 quantum systems installed worldwide, used by an ecosystem of more than 325 entities — from corporations to startups to government labs. Recent wins include a Berkeley Lab simulation using the 156-qubit Heron processor for complex physics, and a Cleveland Clinic team that modelled a protein building block on IBM hardware. Two additional peer-reviewed studies confirmed the practicality of the Nighthawk architecture for cybersecurity and particle physics. And at the end of June, IBM released an open-source extension that spots errors directly inside quantum circuits — a quiet but crucial advance toward error correction.

This blend of steady software revenue and long-shot quantum ambition makes IBM difficult to price. The volatility reading of nearly 70% — far from the image of a staid blue chip — tells the story. Technical traders note that as long as the stock holds above the 50-day moving average at €219.25, the medium-term trend remains intact. But the ultimate test comes in a few weeks. If the Q2 numbers show the AI backlog converting into hard revenue and software growth staying above 10%, the June sell-off will look like a buying opportunity. If not, the fears that drove the drop may prove prophetic.

Ad

IBM Stock: New Analysis - 1 July

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

en | US4592001014 | IBM’S | boerse | 69668589 |